(Q38061846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Ana M Sotoca

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jacques Vervoort

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jochem Louisse

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

1 reference

23 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

Molecular Nutrition and Food Research

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

100-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23175102%20AND%20SRC:MED&resulttype=core&format=json

Contested meanings of the menopause

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Selective estrogen receptor modulators: structure, function, and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Molecular aspects of phytoestrogen selective binding at estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Alternative therapies for menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Phytoestrogens for treatment of menopausal symptoms: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Endocrine disruptors and reproductive health: the case of bisphenol-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

A pilot clinical study of short-term isoflavone supplements in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Various doses of soy isoflavones do not modify mammographic density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Phytoestrogens and breast cancer: a complex story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Is soy consumption good or bad for the breast?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy intake and cancer risk: a review of the in vitro and in vivo data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Phytoestrogens: epidemiology and a possible role in cancer protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Dietary effects on breast-cancer risk in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Meta-analysis of soy intake and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Epidemiology of soy exposures and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The role of early life genistein exposures in modifying breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Case-control study of phyto-oestrogens and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Equol improves menopausal symptoms in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Neonatal genistein chemoprevents mammary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The different roles of ER subtypes in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor-beta: recent lessons from in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The biological role of estrogen receptors alpha and beta in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Tissue-specific regulation of genes by estrogen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptors: how do they signal and what are their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Molecular determinants for the tissue specificity of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen deficiency and bone loss: an inflammatory tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

ER beta inhibits proliferation and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Global gene expression profiles induced by phytoestrogens in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

DNA methylation and the regulation of gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Modulation of gene methylation by genistein or lycopene in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Neomorphic agouti mutations in obese yellow mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Controlling the double helix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Isoflavones stimulate estrogen receptor-mediated core histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Cancer chemoprevention by dietary polyphenols: promising role for epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

The diverse functions of histone lysine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Regulation of estrogen rapid signaling through arginine methylation by PRMT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Mechanisms of microRNA-mediated gene regulation in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Mechanisms of microRNA-mediated gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

miR-146a suppresses invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Estrogen receptor-beta mRNA variants in human and murine tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Coregulators: transducing signal from transcription to alternative splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439

Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200439